Lannett Adds To Respiratory Pipeline With Spiriva Rival

Extension Of Alliance With Respirent Targets $1.5bn US Brand Sales

 
• By David Wallace
Spiriva Handihaler inhaler
Lannett and Respirent are developing a generic Spiriva Handihaler • Source: Alamy

More from Deals

More from Business